Total Funding
21
50
Total FundingSeed raised
Growth Score
-3 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
86492
Aparito digitise clinical trials and capture real-world data through our eCOA platform using video assessments, wearable devices and ePROs
Elin Haf Davies: CEOPast Role: Bangor University, Research Fellow- Chris Tyson: Chief Information OfficerPast Role: AstraZeneca, Consultant
About the Company
Aparito’s mission is to digitise clinical trials and accelerate drug development by supporting patient-centric clinical trials with the Atom5™ eCOA platform.
The Atom5™ platform is Part 11, GDPR and HIPPA compliant and supports clinical trials at scale with video eCOAs, ePROs, Wearables, Telemedicine and eConsent in 193 countries and 125 languages
to capture more frequent patient-generated data in the clinic and at home.
This moves from relying on sterile, snapshot assessments during clinic visits to continuous, real-time, real-world data utilising novel eCOA and digital biomarkers.
